CLJI Worldwide Trial Enrolls First Patient in Clinical Study Evaluating the Performance of VIBLOK as a Barrier for Herpes Simplex Virus Transmission in Men and Women
KLKN-TV Eyewitness News,
SOURCE CLJI Worldwide CLJI Worldwide Sponsored Study Assessing the Safety and Performance of VIBLOK in HSV-2 infected adults as…